An essential and complete guide for the biotechnology companies operating in Singapore.



Temasek unit pares stakes in S Korean pharma firms for as much as S$1.36b


TEMASEK Holdings' unit Ion Investments on Wednesday said it is paring its stakes in two South Korean pharmaceutical companies but will remain a substantial shareholder in both.

Earlier on Tuesday, IFR reported that Ion is selling part of its stakes in Celltrion Inc, and the distributor of its products Celltrion Healthcare.

Citing a term sheet, IFR said that Ion, ...more

New molecule kills drug-resistant bacteria

An international research team has developed a synthetic molecule that can kill five deadly types of multidrug-resistant bacteria with limited side effects, if any.

The hope is that the new material could be developed into a drug to treat patients with antibiotic-resistant infections.

The team was led by the Institute of Bioengineering and Nanotechnology (IBN) of the Agency for ...more

New drug a boost for blood cancer patients

A drug which aims to increase the length of time myeloma patients can spend without the disease getting worse has been approved by the Health Sciences Authority.

Myeloma is an almost incurable blood cancer in the bone marrow or soft tissue. Symptoms include bone pain, kidney failure and anaemia.

Relapses are common due to the disease rarely reaching complete remission. Once diagnosed, ...more

EDB arm joins $661m funding round for biotech company

EDBI, the investment arm of the Economic Development Board, has joined a group of investors in a US$500 million (S$661 million) funding round for Moderna Therapeutics. This gives it a valuation of around US$7 billion and makes it one of the biggest unicorns in the biotech sector. (A unicorn is a start-up valued at over US$1 billion.)

Moderna is a clinical-stage biotech company that is creating ...more